Santina Bruzzone

Title: Santina Bruzzone: Innovator in Antitumour and Anti-inflammatory Research

Introduction

Santina Bruzzone is a notable inventor based in Genoa, Italy. She has made significant contributions to the fields of biochemistry and pharmacology, particularly through her innovative research on adenyl dinucleotides and the use of fluridone as an anti-inflammatory agent. With a total of two patents to her name, her work has the potential to impact medical treatments significantly.

Latest Patents

Santina Bruzzone's latest patents include "Adenyl dinucleotides with antitumour activity and a method of preparing thereof." This invention focuses on novel adenyl dinucleotides that are isomers of the dinucleotide Ap2A, which exhibit antitumour activity, especially against haematological tumours such as leukaemias and lymphomas. The patent also details an enzymatic method for preparing these dinucleotides and an assay method for one of the dinucleotides based on its conversion to NAD. Another significant patent is "Fluridone as an anti-inflammatory agent," which explores the novel use of fluridone, a compound traditionally used as an aquatic herbicide, in the medical field. This patent highlights fluridone's potential as an active compound for preparing medicaments with anti-inflammatory properties.

Career Highlights

Throughout her career, Santina Bruzzone has worked with esteemed institutions such as the University of Genoa and the Advanced Biotechnology Center. Her research has been pivotal in exploring new therapeutic avenues for treating various medical conditions.

Collaborations

Santina has collaborated with notable colleagues, including Elena Zocchi and Lucrezia Guida, contributing to her innovative research and development efforts.

Conclusion

Santina Bruzzone's work exemplifies the intersection of scientific research and practical application in medicine. Her patents not only advance our understanding of biochemistry but also hold promise for future medical treatments.